{"created":"2022-02-22T07:18:54.797196+00:00","id":2016897,"links":{},"metadata":{"_buckets":{"deposit":"434122ec-cbcb-4519-b74a-92d2335780fe"},"_deposit":{"id":"2016897","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"2016897"},"status":"published"},"_oai":{"id":"oai:u-ryukyu.repo.nii.ac.jp:02016897","sets":["1642838163960:1642838198944:1642838199408:1642838231558","1642838403551:1642838412624"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"限局性前立腺癌に対する I-125 密封小線源療法150例の検討","subitem_1551255648112":"ja"},{"subitem_1551255647225":"Clinical analysis of brachytherapy with permanent iodine-125 seed implantation for organ-confined prostate cancer in 150 patients","subitem_1551255648112":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"宮里, 実","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"有賀, 拓郎","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"前本, 均","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"草田, 武朗","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"芦刈, 明日香","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"上間, 南海子","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"宮城, 亮太","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"仲西, 昌太郎","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"呉屋, 真人","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"村山, 貞之","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"斎藤, 誠一","creatorNameLang":"ja"}]},{"creatorNames":[{"creatorName":"Miyazato, Minoru","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ariga, Takuro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Maemoto, Hitoshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kusada, Takeaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ashikari, Asuka","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Uema, Namiko","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Miyagi, Ryota","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nakanishi, Shotaro","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Goya, Masato","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Murayama, Sadayuki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Saito, Seiichi","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_1522299639480":"open access","subitem_1600958577026":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_1522650717957":"ja","subitem_1522651041219":"琉球医学会"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"brachytherapy"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"iodine-125"},{"subitem_1522299896455":"en","subitem_1522300014469":"Other","subitem_1523261968819":"prostate cancer"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Background: We retrospectively evaluated the outcome of brachytherapy with permanent iodine-125 seed implantation for prostate cancer. Methods: From 2009 to2016, 150 patients（49 in low risk, 81 intermediate, 20 high），mean age 67.1 y, which were performed brachytherapy in our hospital were enrolled in this study. Results: The average prostate volume was 27.4cc, mean International Prostate Symptom Score 9 in these patients. In postplan evaluation, mean prostate V100 93.8%, D90 in brachytherapy alone 173.9Gy, combined with external beam radiation 116.8Gy, rectum V100 in brachytherapy alone 0.27cc, combined with external beam radiation 0.13cc, urethraD90 in brachytherapy alone 89.9Gy, combined with external beam radiation 64.4Gy. The biochemical progression-free survival in 5 years was 97.0% in low risk, while 96.3% in intermediate and no patients in high risk demonstrated PSA relapse during the observation. Migration of seeds was occurred in 3.3%. Adverse event was urinary retention in 2, hematuria in 2, proctitis in 2, rectal bleeding in 2, more than grade 3 was noted in only one patient. Conclusions: The outcome of brachytherapy in our hospital was safe and feasible with low side effects.","subitem_description_type":"Other"},{"subitem_description":"論文","subitem_description_type":"Other"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_1522300295150":"ja","subitem_1522300316516":"琉球医学会"},{"subitem_1522300295150":"en","subitem_1522300316516":"Ryukyu Medical Association"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_1551255818386":"jpn"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_1522646500366":"ISSN","subitem_1522646572813":"1346-888X"},{"subitem_1522646500366":"NCID","subitem_1522646572813":"AN10369445"}]},"item_1617186941041":{"attribute_name":"Source Title","attribute_value_mlt":[{"subitem_1522650068558":"ja","subitem_1522650091861":"琉球医学会誌 = Ryukyu Medical Journal"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueNumber":"1-4","bibliographicPageEnd":"17","bibliographicPageStart":"13","bibliographicVolumeNumber":"37"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_1522305645492":"VoR","subitem_1600292170262":"http://purl.org/coar/version/c_970fb48d4fbd8a85"}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","filename":"Vol37(1-4)p13.pdf","mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://u-ryukyu.repo.nii.ac.jp/record/2016897/files/Vol37(1-4)p13.pdf"},"version_id":"57ba5324-5358-47b4-881c-16db37ec1223"}]},"item_title":"限局性前立腺癌に対する I-125 密封小線源療法150例の検討","item_type_id":"15","owner":"1","path":["1642838231558","1642838412624"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-11-29"},"publish_date":"2019-11-29","publish_status":"0","recid":"2016897","relation_version_is_last":true,"title":["限局性前立腺癌に対する I-125 密封小線源療法150例の検討"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2022-02-22T07:19:00.123108+00:00"}